Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Nassif is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a physician-scientist in the Department of Sarcoma Medical Oncology. I received my medical degree in 2014 and my medical oncology specialty in 2020 from Paris University (France). During my residency and fellowship in France, I trained at Gustave Roussy Cancer Center and completed a master of science in Immunology in 2019. After completion of my clinical training, I pursued a research post-doctoral fellowship at MD Anderson during two years, focusing on characterizing the immune microenvironment of sarcomas and identifying new immune therapeutic targets to improve sarcoma care. I have a particular interest in the care of patients with leiomyosarcomas and undifferentiated pleomorphic sarcomas. My main research focus are leiomyosarcomas, undifferentiated pleomorphic sarcomas, i mmunotherapy, and drug development in sarcomas.
Education & Training
OtherClass of 2020
Certifications & Licensure
TX State Medical License 2023 - 2025
Clinical Trials
- A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions Start of enrollment: 2024 Aug 14
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 2 citationsMargin Width and Local Recurrence in Patients with Phyllodes Tumors of the Breast.Haydee Del Calvo, Yun Wu, Heather Y Lin, Elise F Nassif, Maria A Zarzour
Annals of Surgical Oncology. 2024-11-01 - 1 citationsHigh Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma.Raymond S Traweek, Heather G Lyu, Russell G Witt, Rebecca A Snyder, Elise F Nassif
Annals of Surgical Oncology. 2024-06-01 - Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort.Michael S Nakazawa, J Andrew Livingston, Maria A Zarzour, Andrew J Bishop, Ravin Ratan
Rare Tumors. 2024-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
